Clinical Trials Find Success with Use of Next-Generation Gene Sequencing; Could Lead to More Precise Clinical Pathology Laboratory Tests

Pathologists and medical lab scientists may do more consults with interdisciplinary teams in connection with biomarker-based phase I clinical trial selection Scientists are beginning to incorporate next-generation gene sequencing into a growing number of clinical trials. This is an important development because knowledge developed in clinical trials often forms the foundation for the evidence-based medicine guidelines issued following a successful clinical trial. Further, these new uses for...

Oregon’s New Medicaid Care Model Uses Capitated Reimbursement and Coordinated Care Organizations; May Change How Clinical Laboratories Are Paid

Other states are studying Oregon’s innovative Medicaid experiment, which could lead to different forms of reimbursement for clinical laboratories Once again, Oregon’s Medicaid program is blazing a new trail in the delivery of healthcare. This time, Oregon is organizing its Medicaid services—known as the Oregon Health Plan—to do two things. First, it is developing 16 coordinated care organizations (CCOs)  across the state. Second, those Medicaid beneficiaries who represent the majority of costs...
;